Sponsored Content
Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.
Press Wire ♦
Published: May 21, 2013; 08:31 ♦ (Vindobona)

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.

Company Information
Wien (euro adhoc) - Vienna (Austria), May 21, 2013 - Intercell AG (VSE; "ICLL")
announced today that the pediatric indication for IXIARO®, a vaccine to protect
against Japanese Encephalitis (JE), was…
or Log In
Fast News Search
ISIN